| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447451 | European Journal of Cancer | 2011 | 12 Pages |
Abstract
The outcome of this discussion is summarised here. Guidance for management of these adverse events is provided. Both clinicians and patients should be aware of the potential side-effects of everolimus and understand that these side-effects are manageable with standard care to optimise patient benefit.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Camillo Porta, Susanne Osanto, Alain Ravaud, Miguel-Angel Climent, Ulka Vaishampayan, Dorothy A. White, Patricia Creel, Brenda Dickow, Patricia Fischer, Suzanne Sweeney Gornell, Federica Meloni, Robert J. Motzer,